Jci_page_head_homepage_01 Jci_page_head_homepage_02
Irini Bournazou, John D. Pound, Rodger Duffin, Stylianos Bournazos, Lynsey A. Melville, Simon B. Brown, Adriano G. Rossi, Christopher D. Gregory
Published in Volume 119, Issue 1
J Clin Invest. 2009; 119(1):20–32 doi:10.1172/JCI36226
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0936226
Figure 7
Effect of lactoferrin on neutrophil activation status.

The expression of CD62L (A and B) and CD11b (C and D) was assessed in fMLP- (100 nM), TNF-α– (1 ng ml), or PMA-stimulated (100 nM) neutrophils (30 minutes at 37°C) that were preincubated (40 minutes at 37°C) in the presence or absence of lactoferrin (10 μg/ml). Representative flow cytometry overlays of CD62L (A) and CD11b (C) expression in control (gray) and stimulated neutrophils (lactoferrin-treated: red; untreated: blue). n = 3; *P < 0.05, **P < 0.01. Error bars indicate SEM. (E) Western blot analysis to determine levels of ERK1/2 phosphorylation. Neutrophils were incubated with lactoferrin (10 μg/ml; 40 minutes at 37°C), followed by stimulation with fMLP (100 nM) for the indicated times. Membrane was stripped and reprobed for total ERK2. Results are representative of 3 independent experiments.